
Are orange cats really the goofiest cats? Genetics may have an answer.
Hanging from lamps, catapulting off countertops, tackling the dog, biting your legs unexpectedly—there are many wacky behaviors associated with orange cats, often captured on TikTok, whose owners swear are extra derpy, slapdash, and yet also friendly to a fault.
But scientifically speaking, are orange cats actually any different than cats of other colors?
For starters, orange cats are not a breed, like British shorthair or Siamese. Cats of many breeds, from Maine coons and munchkins to American bobtails and Siberians, can have orange colorations. Which perhaps makes it all the weirder that orange cat aficionados claim that orange cat behaviors transcend breed.
Earlier this year scientists identified the gene responsible for the orange coat coloration found in cats. It's called ARHGAP36. But as to whether orange coloration also comes with a suite of behaviors or personality traits, much less is known.
(Surprising things you never knew about your cat)
In 2015, a small study published in the journal Anthrozoös used an anonymous online poll to find that people were at least more likely to attribute the trait 'friendliness' to orange cats than other cat colors. And a larger study published in the Journal of Veterinary Behavior in the same year also found some support to the idea that orange cats are distinct.
'We found that most of the differences are breed-related, but there were also some differences related to coat color,' says Carlo Siracusa, a clinical scientist at the School of Veterinary Medicine at the University of Pennsylvania and senior author of the study.
Lilac-colored cats, for instance, were found to be more playful and more likely to experience separation anxiety. Piebald cats, or those with white patches, had decreased vocalization scores. And cats with a tortoiseshell pattern were less aggressive toward dogs.
But orange cats?
'It's interesting that you mention orange cats being more outgoing, more gregarious, because actually, we found the opposite,' says Siracusa. 'They were more likely to show fear-related aggressions towards unfamiliar people.' Orange cats were also linked to a heightened interest in prey. Digging into the science on orange cats
While Siracusa's research may be some of the best we have when it comes to attributing any behavior to cat colors, he is quick to qualify the findings.
'Our assessment was done through questions sent to owners. It was not done via direct observation,' he says. 'Every time you use a questionnaire, you are assuming the risk of bias, because you are asking people what they think about something.'
Therefore, it may just be that the idea of orange cats being extra sassy is so prominent, that bias is showing up in studies.
Even with that knowledge though, Siracusa says biases are often grounded in experience. And as someone who handles cats on a regular basis, he has his own experience-based beliefs, such as male cats being more outgoing than females.
'My perception itself, at this point, is a bias,' he laughs. Orange cat behavior—what we do know
Even without a slam-dunk study connecting a cat's orange-ness to its personality, there are hints at a biological link.
Remember the ARHGAP36 gene that provides orange coloration? Well, it's linked to the X-chromosome. This explains why orange cats are more likely to be male, the authors report in the study published in Current Biology.
Female cats have two X chromosomes. And that means they must possess two copies of the gene in order to produce orange coloration. But males, which have XY chromosomes, need just one copy of ARHGAP36, to develop orange colorations. Perhaps this is the real answer to orange cat quirkiness: Siracusa tends to think that, in general, male cats are more outgoing.
But, here's where things get interesting.
As scientists learn more about genes and how they influence development, they have learned that any given gene is often linked with a variety of downstream traits. For instance, people with red hair have a variant of the melanocortin-1 receptor (MC1R) gene, which may also be linked to a higher tolerance of pain and reduced effectiveness of anesthesia.
Now, in studies of humans and mice, the ARHGAP36 gene is expressed in the brain and hormonal glands. Even more interestingly, the cells that give fur or skin color, known as pigment cells, actually begin their development in the neural crest cells of an embryo.
(Here's how your cat experiences the world)
These cells can also 'differentiate into neurons and endocrine cells that produce catecholamines, which are known to control activity and excitability,' says Hiroyuki Sasaki, an emeritus professor and geneticist at Kyushu University in Japan, in an email.
'It thus seems possible that the DNA mutation in the gene could cause changes in temperaments and behaviors,' says Sasaki, who is senior author on the study. 'I should like to stress, however, that this is just a speculation.' Cats are individuals, too
Even if there was some scientific underpinning for ginger cat behavior, the scientists stress, there would always likely be exceptions to the rules.
'This is what we see in the clinics every day,' says Siracusa, who says clients frequently tell him they selected a certain breed or color pet for its prescribed behavior. 'And then they have an animal that behaves in a completely opposite manner, and they are shocked,' he says.
(How diverse personalities help animals survive)
With nearly 74 million pet cats in the United States alone, you might wonder how it is that anything remains a mystery about the companion animals.
But questions that are not linked to urgent human or animal health issues often go overlooked and underfunded, says Sasaki.
'Our world is still full of mystery, and there are so many unanswered questions around us, including those that may seem very simple,' says Sasaki.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Hill
13 minutes ago
- The Hill
Senate Republican questions new Intel CEO's ties to China
Sen. Tom Cotton (R-Ark.) on Tuesday pressed the chair of Intel's board about its CEO's ties to China, voicing concerns about the integrity of the semiconductor firm and U.S. national security. In a letter to Intel board chair Frank Yeary, Cotton pointed to recent reporting on Lip-Bu Tan's investments in hundreds of Chinese tech firms, at least eight of which have ties to the Chinese military, according to Reuters. Tan was tapped to lead Intel in March, after former CEO Pat Gelsinger stepped down last December following a 'challenging year' for the company. Before joining Intel, Tan was CEO of Cadence Design Systems — another point of concern raised by Cotton. The software company produces electronic design automation (EDA) technology, which is used to design chips. It agreed to plead guilty and pay $140 million last month for violating export controls by selling the technology to a Chinese military university. 'Intel is required to be a responsible steward of American taxpayer dollars and to comply with applicable security regulations,' Cotton wrote, noting Intel's nearly $8 billion grant under the CHIPS and Science Act. 'Mr. Tan's associations raise questions about Intel's ability to fulfill these obligations,' he added. Cotton asked Yeary what measures Intel has taken to address concerns about Cadence's activities, which occurred during Tan's tenure, and whether it has required him to divest from China-linked semiconductor firms or other 'concerning entities.' The Arkansas Republican also questioned whether Tan has disclosed his China investments and ties to the U.S. government given Intel's involvement in a Pentagon program to build chips for defense and intelligence needs.
Yahoo
20 minutes ago
- Yahoo
Short, Brisk Walks Could Help You Live Longer Than Long, Slow Strolls
The speed of your steps could make a significant difference in adding years to your life, according to a new study. Researchers led by a team from Vanderbilt University in the US analyzed the physical activity of 79,856 adults in 12 US states, comparing links between time spent walking slowly, time spent walking quickly, and eventual cause of death (where applicable) across an average follow-up period of almost 17 years. The data showed that those people who spent at least a quarter of an hour each day walking briskly were significantly less likely to die during the study period, especially from cardiovascular disease. What makes the findings particularly useful is they're based on a sample that includes people typically underrepresented in walking studies like this: the cohort was predominantly made up of low-income and Black individuals, who are often more likely to live in impoverished areas and less likely to have access to safe walking spaces. Related: "Our research has shown that fast walking as little as 15 minutes a day was associated with a nearly 20 percent reduction in total mortality, while a smaller reduction in mortality was found in association with more than three hours of daily slow walking," says epidemiologist Wei Zheng, from Vanderbilt University "This benefit remained strong even after accounting for other lifestyle factors and was consistent across various sensitivity analyses." The researchers categorized slow walking as walking the dog, or walking around at work. To qualify for the faster walking linked to the reduction in the risk of death, it had to be something like climbing stairs or walking briskly as part of an exercise routine. While the study isn't comprehensive enough to show direct cause and effect, the drop in mortality risk is significant enough to strongly suggest some kind of link, and the researchers think the benefits that aerobic exercise brings to heart health is key. Fast walking makes the heart work harder, improving cardiovascular health. Burning calories can also help people stick to a healthy weight. "While the health benefits of daily walking are well established, limited research has investigated the effects of factors such as walking pace on mortality, particularly in low-income and Black/African-American populations," says Zheng. One of the reasons that researchers are so keen to promote walking as a way of staying healthy is that it's just about the simplest exercise out there: most of us can do it, without any special equipment, and it's relatively easy to roll into a daily routine (try parking a little further away from work, for example). "Public health campaigns and community-based programs can emphasize the importance and availability of fast walking to improve health outcomes, providing resources and support to facilitate increased fast walking within all communities," says epidemiologist Lili Liu, from Vanderbilt University. The research has been published in the American Journal of Preventative Medicine. Related News 5 Things You Ought to Know Before Buying Supplements There's One Simple Method to Reduce Alcohol Intake, Scientists Say, And It Works Untested Peptide Injections Are Being Sold as 'Next-Gen Biohacks' Solve the daily Crossword


USA Today
3 hours ago
- USA Today
RFK Jr. is canceling mRNA vaccine development. Can I still get a COVID vaccine?
Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks than benefits. In a video posted on X Aug. 5, Kennedy said the decision will impact 22 projects worth nearly $500 million at the Biomedical Advanced Research and Development Authority, which helps companies develop medical supplies to address public health threats. Messenger RNA, or mRNA, is used in the two most common COVID-19 vaccines licensed in the U.S. Kennedy's announcement has raised questions about these vaccines, how mRNA works and what this decision means for future research. "This technology played a vital role in our pandemic response and continues to show promise for treating serious diseases," said Jeff Coller, Bloomberg Distinguished Professor of RNA biology and therapeutics at Johns Hopkins University. "As other countries advance these proven, safe and effective therapies, American patients may increasingly depend on foreign innovation for breakthrough treatments." How do mRNA vaccines work? The COVID-19 vaccine works by instructing the body's immune system to recognize the virus and creating fighting antibodies to attack it. Messenger RNA, or mRNA, is a code that tells the body's cells to produce just a piece of the virus, the protein on the surface. The code is protected by a lipid coating, like a fat bubble. mRNA vaccines: RFK Jr. to wind down $500M vaccine development Once injected into the body, the vaccine releases the mRNA to program the cell to produce the spike proteins like those on the surface of SARS-CoV-2, the COVID-19 virus. Our immune system recognizes those vaccine-created spike proteins as invaders and creates antibodies to block future attacks from the virus. Messenger RNA vaccines contain only a fraction of the virus, so unlike some vaccines, they can't give people the disease they're trying to prevent or trigger allergies to eggs or other traditional vaccine ingredients. Should I expect a COVID vaccine this fall? It's unclear whether patients should be expecting COVID-19 vaccines this fall, said Dr. Beth Oller, a family physician in Stockton, Kansas, and clinical instructor at the University of Kansas School of Medicine-Wichita. In June, Kennedy fired all members of the Advisory Committee on Immunization Practices, a key vaccine panel that makes recommendations for COVID-19 and other vaccines, and appointed eight new members. During its first meeting, the committee did not make any recommendations for the fall and isn't expected to reconvene until "September/October," according to the Centers for Disease Control and Prevention website. Kennedy said on May 27 that the COVID-19 vaccine would no longer be included in the CDC's recommended immunization schedule for healthy children and pregnant women, a move that broke with previous expert guidance and bypassed the normal scientific review process. Under the changes, the only people who will be recommended for COVID-19 vaccines are those over 65 and people with existing health problems. This could make it harder for others who want the COVID-19 vaccine to get it, including health care workers and healthy people under 65 with a vulnerable family member or those who want to reduce their short-term risk of infection. The American College of Obstetricians and Gynecologists (ACOG) and American Academy of Pediatrics (AAP), among other organizations, issued statements condemning the change, with the ACOG saying it was "...concerned about and extremely disappointed by the announcement that HHS will no longer recommend COVID-19 vaccination during pregnancy." Will insurance cover my COVID shot? Many consumers are worried about possible cuts to health insurers' coverage of vaccines, a recent poll said. A KFF poll published Aug. 1 found 40% of adults said they will "definitely" or "probably" get a COVID-19 vaccine shot. Of those who intend to get vaccinated, 62% said they are worried insurance won't cover the cost of the vaccine. Groups representing commercial health insurance companies said they still plan to cover vaccines recommended by the CDC and ACIP, the vaccine advisory panel. "Health plans continue to follow federal requirements related to coverage of ACIP-recommended vaccines and will continue to support broad access to critical preventive services, including immunizations," said Tina Stow, spokesperson for AHIP, which represents health insurance companies. COVID: As new variant spreads, what's the latest vaccine guidance? The CDC currently recommends shared decision-making between parents and doctors for immunizing children with the COVID-19 vaccine. It also recommends vaccines for people who are moderately or severely immune compromised. Large employers that provide health insurance benefits for workers and their families will likely continue to cover Food and Drug Administration-approved vaccines, said James Gelfand, president and CEO of the ERISA Industry Committee. In some cases, employer vaccine coverage might follow FDA approvals rather than narrower ACIP Mary Walrath-Holdridge Adrianna Rodriguez can be reached at adrodriguez@